Anebulo Pharmaceuticals, Inc. - stock earnings
ANEB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -2.7 million USD | ? USD |
| 2023Q3 | -2.5 million USD | ? USD |
| 2023Q2 | -2.5 million USD | ? USD |
| 2023Q1 | -2.7 million USD | ? USD |
| 2022Q4 | -3.8 million USD | ? USD |
| 2022Q3 | -2.6 million USD | ? USD |
| 2022Q2 | -2.3 million USD | ? USD |
| 2022Q1 | -1.9 million USD | ? USD |
| 2021Q4 | -1.1 million USD | ? USD |
| 2021Q3 | -1.6 million USD | ? USD |
| 2021Q2 | -29.1 million USD | ? USD |
| 2021Q1 | -555832 USD | ? USD |
| 2020Q4 | -328604 USD | ? USD |
| 2020Q3 | -256379 USD | ? USD |
ANEB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -11.7 million USD | ? USD |
| 2022 | -6.8 million USD | ? USD |
| 2021 | -30.3 million USD | ? USD |
| 2020 | -30.3 million USD | ? USD |
| 2019 | -174637 USD | ? USD |
ANEB
Price: $2.95
52 week price:
Earnings Per Share: -0.41 USD
P/E Ratio: -5.39
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 1471
Market Capitalization: 72.1 million